United Therapeutics (UTHR) Other Working Capital Changes (2009 - 2026)

United Therapeutics has disclosed Other Working Capital Changes across 18 years of filings, most recently posting -$27.0 million for Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at -$27.0 million, up 79.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $188.4 million (up 379.11% YoY), and the FY2025 annual result was $80.9 million, up 1051.76% from the prior year.
• Other Working Capital Changes came in at -$27.0 million for Q1 2026 at United Therapeutics, down from $98.2 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $184.4 million in Q2 2025 to a low of -$134.5 million in Q1 2025.
• The 5-year median for Other Working Capital Changes is -$27.0 million (2024), against an average of $12.6 million.
• Across the five-year window, Other Working Capital Changes soared 648.41% in 2022 and sank 1086.05% in 2024, its largest moves.
• United Therapeutics' Other Working Capital Changes stood at $94.3 million in 2022, then plunged by 124.5% to -$23.1 million in 2023, then slipped by 16.88% to -$27.0 million in 2024, then soared by 463.7% to $98.2 million in 2025, then sank by 127.49% to -$27.0 million in 2026.
• The last three Other Working Capital Changes figures came in at -$27.0 million (Q1 2026), $98.2 million (Q4 2025), and -$67.2 million (Q3 2025), per Business Quant data.